A combination of p300 and Braf expression in the diagnosis and prognosis of melanoma

BACKGROUND: To date only a handful of drugs are available for the treatment of melanoma. Among them vemurafenib, a Braf(V600E) specific inhibitor, showed promising results in terms of response rate and increase in median survival time. However, its effectiveness is limited by development of resistan...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Bhandaru, Madhuri, Ardekani, Gholamreza Safaee, Zhang, Guohong, Martinka, Magdalena, McElwee, Kevin J, Li, Gang, Rotte, Anand
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2014
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4051389/
https://ncbi.nlm.nih.gov/pubmed/24893747
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-14-398
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller